Skip to main content
Log in

Moxibustion treatment restoring the intestinal epithelium barrier in rats with Crohn’s disease by down-regulating tumor necrosis factor alpha, tumor necrosis factor receptor 1, and tumor necrosis factor receptor 2

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To investigate whether moxibustion regulates tumor necrosis factor alpha (TNF-α), tumor necrosis factor receptor 1 (TNFR1), and TNFR2 in the intestinal mucosa and to explore whether moxibustion could be used by means of this mechanism, to repair the intestinal epithelium barrier disruption in Crohn’s disease (CD).

Methods

The CD rat models were established by trinitrobenzene sulfonic acid (TNBs), randomly divided into a model control (MC) group, an herb-partition moxibustion (HPM) group, a mild-warm moxibustion (MWM) group, and a salicylazosulfapyridine (SASP) group, and all were compared with a normal control (NC) group. The HPM and MWM groups were treated by moxibustion at Tianshu (ST25) and Qihai (RN6) for 14 days, and the SASP group obtained the SASP solution orally for the same period of time. The intestinal epithelium morphology and TNF-α, TNFR1, and TNFR2 contents were observed by the transmission electron microscopy and enzyme linked immunosorbent assay.

Results

The severity of morphological changes in CD intestinal epithelium was obviously improved, and the levels of TNF-α, TNFR1, and TNFR2 in the intestinal mucosa all significantly decreased in the HPM and MWM groups. However, there were no significant differences between the HPM and MWM groups.

Conclusion

The moxibustion therapies (HPM and MWM) could reduce intestinal inflammation and restore intestinal epithelium barrier disruption in CD, which might be due to down-regulating TNF-α, TNFR1, and TNFR2 in intestinal mucosa and improving intestinal epithelium morphology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Li Q, Zhang Q, Wang M, Zhao S, Ma J, Luo N, et al. Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction. Clin Immunol 2008;126:67–80.

    Article  PubMed  CAS  Google Scholar 

  2. Ye D, Ma I, Ma TY. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 2006;290:G496–504.

    Article  PubMed  CAS  Google Scholar 

  3. van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, et al. Treatment of Crohn’s disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129–135.

    Article  PubMed  Google Scholar 

  4. Suenaert P, Bulteel V, Lemmens L, Noman M, Geypens B, Van Assche G, et al. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn’s disease. Am J Gastroenterol 2002; 97: 2000–2004.

    Article  PubMed  CAS  Google Scholar 

  5. Hanauer SB, Sandborn WJ, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh D, et al. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-I trial. Gastroenterology 2006;130:323–333.

    Article  PubMed  CAS  Google Scholar 

  6. Mitoma H, Horiuchi T, Hatta N, Tsukamoto H, Harashima S, Kikuchi Y, et al. Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha. Gastroenterology 2005;128:376–392.

    Article  PubMed  CAS  Google Scholar 

  7. Shi Y, Liu HR, Hua WG, Qin XD, Wu HG, Qian JL. Study on the modulating mechanism of colonic TNF-α and IL-10mRNA expression in CD rats with acupuncture and moxibustion. Chin Arch Tradit Chin Med (Chin) 2005;23:272–275.

    Google Scholar 

  8. Shi Y, Wu HG. Clinical research of herbs-partition moxibustion treating Crohn’s disease. Jiangxi J Tradit Chin Med (Chin) 2003;34(8):16–17.

    Google Scholar 

  9. Shi Y, Wu HG, Qin XD, Tan LY, Zhang W, Hua XG, et al. The acupuncture effect on E-selectin and ICAM-1 expression in the colonic mucosa with Crohn’s disease rats. J Jiangxi Univ Tradit Chin Med (Chin) 2005;17:37–39.

    Google Scholar 

  10. Liu HR, Hua XG, Shi Y, Tan LY, Zhang LS. Effects of acupuncture and moxibustion on substance P and neurokinin-1 receptor in Crohn’s disease rats. Acta Univ Tradit Med Sinensis Pharmacol Shanghai (Chin) 2005;19(2): 48–50.

    Google Scholar 

  11. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96:795–803.

    PubMed  CAS  Google Scholar 

  12. Elson CO. Genes, microbes, and T cells-new therapeutic targets in Crohn’s disease. N Engl J Med 2002;346:614–616.

    Article  PubMed  Google Scholar 

  13. Shanahan F. Crohn’s disease. Lancet 2002;359:62–69.

    Article  PubMed  CAS  Google Scholar 

  14. Shen L, Su L, Turner JR. Mechanisms and functional implications of intestinal barrier defects. Dig Dis 2009;27:443–449.

    Article  PubMed  Google Scholar 

  15. Mankertz J, Schulzke JD. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol 2007;23:379–383.

    Article  PubMed  CAS  Google Scholar 

  16. Troeger H, Richter JF, Beutin L, Günzel D, Dobrindt U, Epple HJ, et al. Escherichia coli alpha-haemolysin induces focal leaks in colonic epithelium: a novel mechanism of bacterial translocation. Cell Microbiol 2007;9:2530–2540

    Article  PubMed  CAS  Google Scholar 

  17. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995;270:1203–1207.

    Article  PubMed  CAS  Google Scholar 

  18. Bitton A, Dobkin PL, Edwardes MD, Sewitch MJ, Meddings JB, Rawal S, et al. Predicting relapse in Crohn’s disease: a biopsychosocial model. Gut 2008; 57:1386–1392.

    Article  PubMed  CAS  Google Scholar 

  19. Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005;129:550–564.

    PubMed  CAS  Google Scholar 

  20. Apostolaki M, Armaka M, Victoratos P, Kollias G. Cellular mechanisms of TNF function in models of inflammation and autoimmunity. Curr Dir Autoimmun 2010;11:1–26.

    Article  PubMed  CAS  Google Scholar 

  21. Hehlgans T, Mannel DN. The TNF-TNF receptor system. Biol Chem 2002;383:1581–1585.

    Article  PubMed  CAS  Google Scholar 

  22. Ma TY, Boivin MA, Ye D, Pedram A, Said HM. Mechanism of TNF-alpha modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol 2005;288:G422–430.

    Article  PubMed  CAS  Google Scholar 

  23. Guy-Grand D, DiSanto JP, Henchoz P, Malassis-Séris M, Vassalli P. Small bowel enteropathy: role of intraepithelial lymphocytes and of cytokines (IL-12, IFN-gamma, TNF) in the induction of epithelial cell death and renewal. Eur J Immunol 1998;28:730–744.

    Article  PubMed  CAS  Google Scholar 

  24. Gitter AH, Bendfeldt K, Schulzke JD, Fromm M. Leaks in the epithelium barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. FASEB J 2000;14:1749–1753.

    Article  PubMed  CAS  Google Scholar 

  25. Schulzke JD, Bojarski C, Zeissig S, Heller F, Gitter AH, Fromm M. Disrupted barrier function through epithelial cell apoptosis. Ann N Y Acad Sci 2006;1072:288–299.

    Article  PubMed  CAS  Google Scholar 

  26. von Boyen GB, Steinkamp M, Geerling I, Reinshagen M, Schäfer KH, Adler G, et al. Pro-inflammatory cytokines induce neurotrophic factor expression in enteric glia: a key to the regulation of epithelial apoptosis in Crohn’s disease. Inflamm Bowel Dis 2006;12:346–354.

    Article  Google Scholar 

  27. Schmitz H, Fromm M, Bentzel CJ, Scholz P, Detjen K, Mankertz J, et al. Tumor necrosis factor-alpha (TNF alpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci 1999;112(pt 1):137–146.

    PubMed  CAS  Google Scholar 

  28. Bruewer M, Samarin S, Nusrat A. Inflammatory bowel disease and the apical junctional complex. Ann N Y Acad Sci 2006;1072:242–252.

    Article  PubMed  CAS  Google Scholar 

  29. Clayburgh DR, Shen L, Turner JR. A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 2004;84:282–291.

    Article  PubMed  CAS  Google Scholar 

  30. Laukoetter MG, Bruewer M, Nusrat A. Regulation of the intestinal epithelial barrier by the apical junctional complex. Curr Opin Gastroenterol 2006;22:85–89.

    Article  PubMed  Google Scholar 

  31. Gibson PR. Increased gut permeability in Crohn’s disease: is TNF the link? Gut 2004;53:1724–1725.

    Article  PubMed  CAS  Google Scholar 

  32. Hollander D. Crohn’s disease, TNF-alpha, and the leaky gut: the chicken or the egg? Am J Gastroenterol 2002; 97:1867–1868.

    PubMed  Google Scholar 

  33. Stallmach A, Giese T, Schmidt C, Ludwig B, Mueller-Molaian I, Meuer SC. Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn’s disease. Int J Colorect Dis 2004;19:308–315.

    Article  Google Scholar 

  34. Raddatz D, Bockemuhl M, Ramadori G. Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome. Eur J Gastroenterol Hepatol 2005;17:547–557.

    Article  PubMed  CAS  Google Scholar 

  35. Laukoetter MG, Nava P, Nusrat A. Role of the intestinal barrier in inflammatory bowel disease. World J Gastroenterol 2008;14:401–407.

    Article  PubMed  CAS  Google Scholar 

  36. Joos S, Brinkhaus B, Maluche C, Maupai N, Kohnen R, Kraehmer N, et al. Acupuncture and moxibustion in the treatment of active Crohn’s disease: a randomized controlled study. Digestion 2004;69:131–139.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Huan-gan Wu  (吴焕淦).

Additional information

Supported by National Basic Research Program of China (973 Program, No. 2009CB522900), National Natural Science Foundation of China (No. 30772831), and the Open Fund of Key Laboratory of Acupuncture Combined with Medication (Najing University of Traditional Chinese Medicine), Ministry of Education (Grant No. KJA200809)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shi, Y., Zhou, Eh., Wu, Hg. et al. Moxibustion treatment restoring the intestinal epithelium barrier in rats with Crohn’s disease by down-regulating tumor necrosis factor alpha, tumor necrosis factor receptor 1, and tumor necrosis factor receptor 2. Chin. J. Integr. Med. 17, 212–217 (2011). https://doi.org/10.1007/s11655-011-0669-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-011-0669-3

Keywords

Navigation